The second part of our 1st phase study has just been successfully completed with no Serious Adverse Events.

Drug administration was performed on ECU, where Subjects were provided with carefull medical care. As a standard, Team of Specialists (Anesthesiologist, Psychiatrist, two Investigators and Nurses) was present during the procedure just to assure maximum safety and quality of recorded data. Vital signs of the Subjects were constantly monitored (BP holter and ECG monitoring) and assessed by a Physician.